Fidson partners research firm on tablet study

Fidson partners research firm on tablet study

Fidson Healthcare Plc has announced plans to conduct a Bioequivalence study on the production of chewable formulation of Albendazole tablets in partnership with Liddie BE Limited, a leading clinical research organisation. Albendazole tablet is a worm medication approved by the  United States Food and Drug Administration for the treatment of a variety of parasitic worm

Read More


Discover more from HOT SOURCE NEWS

Subscribe to get the latest posts sent to your email.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Discover more from HOT SOURCE NEWS

Subscribe now to keep reading and get access to the full archive.

Continue reading